COLGATE-PALMOLIVE COMPANY 2Q 2025 EARNINGS PRESENTATION

    COLGATE-PALMOLIVE COMPANY 2Q 2025 EARNINGS PRESENTATION

    F2 weeks ago 5

    AIAI Summary

    toggle
    Bulleted
    toggle
    Text

    Key Insights

    Loading...

    COLGATE-PALMOLIVE 
COMPANY
2Q 2025 EARNINGS 
PRESENTATION
AUGUST 1, 2025
    1/29

    Loading...

    August 2025 
Notice for Investor Presentation 
Please review the following second quarter 2025 earnings presentation in conjunction with our second quarter 2025 earnings press 
release, our second quarter 2025 prepared management remarks and additional information regarding our non-GAAP financial measures, 
including GAAP to non-GAAP reconciliations, which are available in the Investor Center section of our website at 
www.colgatepalmolive.com/investors and in the second quarter 2025 earnings press release. Our presentation contains non-GAAP 
financial measures, which differ from our reported results prepared in accordance with U.S. generally accepted accounting principles 
(GAAP). These non-GAAP financial measures of operating results exclude items that, either by their nature or amount, management would 
not expect to occur as part of the Company’s normal business on a regular basis, such as restructuring charges, charges for certain 
litigation and tax matters, acquisition-related costs, gains and losses from certain divestitures and certain other unusual, non-recurring 
items. We may also refer to organic sales growth, which is Net sales growth excluding the impact of foreign exchange, acquisitions and 
divestments, or to free cash flow before dividends, which we define as Net cash provided by operations less Capital expenditures. A 
complete, quantitative reconciliation between our reported results and these non-GAAP financial measures is available in the Investor 
Center section of our website at www.colgatepalmolive.com/investors and in Tables 4, 6, 7, 8 and 9 of the second quarter 2025 earnings 
press release.
Our presentation may contain forward-looking statements (as that term is defined in the U.S. Private Securities Litigation Reform Act 
of 1995 or by the Securities and Exchange Commission (the SEC) in its rules, regulations and releases) that set forth anticipated results 
based on management’s current plans and assumptions. These statements are made on the basis of our views and assumptions as of 
August 1, 2025, and we undertake no obligation to update these statements whether as a result of new information, future events or 
otherwise, except as required by law or by the rules and regulations of the SEC. Moreover, we do not, nor does any other person, assume 
responsibility for the accuracy and completeness of these statements. We caution investors that forward-looking statements are not 
guarantees of future performance and actual events or results may differ materially from those statements. For information about factors 
that could impact the Company’s business and cause actual results to differ materially from forward-looking statements, refer to the 
Company’s filings with the SEC (including, but not limited to, the information set forth under the captions “Risk Factors” and “Cautionary 
Statement on Forward-Looking Statements” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024 and 
subsequent filings with the SEC). Copies of these filings are available in the Investor Center section of our website at 
www.colgatepalmolive.com/investors or may be obtained upon request from the Company’s Investor Relations Department.
    2/29

    Loading...

    COLGATE-PALMOLIVE 
We are a $20.1B global consumer products company with ~34,000 
diverse and dedicated people serving over 200 countries and territories. 
As a caring, innovative growth company, we are united behind our purpose: 
reimagining a healthier future for all people, their pets and our planet.
    3/29

    Loading...

    TIGHTLY FOCUSED ON 
FOUR ATTRACTIVE CORE 
CATEGORIES
    4/29

    Loading...

    PERSONAL CARE HOME CARE
ORAL CARE PET NUTRITION
    5/29

    Loading...

    “I am pleased that Colgate-Palmolive people 
achieved another quarter of net sales, organic sales 
and earnings per share growth in the face of 
continued difficult market conditions worldwide, with 
organic sales growth improving sequentially versus 
the first quarter despite an even greater negative 
impact from lower private label pet sales.”
- Noel Wallace, Chairman, President and Chief Executive Officer
    6/29

    Loading...

    2Q 2025 HIGHLIGHTS
● Delivered solid results, including net sales, organic sales and 
EPS growth, despite a challenging operating environment 
● Net sales increased 1.0%; Organic sales* increased 1.8%, 
including a 0.6% negative impact from lower private label pet 
sales
● Organic sales increased sequentially versus 1Q 2025
● Base Business EPS* increased 1%
● Global toothpaste market share was up 20 basis points on a 
volume basis year to date
● The acquisition of the Prime100 fresh pet food business closed 
on April 30, 2025
*Non-GAAP
    7/29

    Loading...

    COLGATE-PALMOLIVE COMPANY 2Q 2025 EARNINGS PRESENTATION - Page 8
    8/29

    Loading...

    NEW PRODUCTIVITY PROGRAM
● Announced a new three-year productivity program to drive 
future growth and support the Company’s 2030 strategy
● Includes initiatives to better align the Company’s 
organizational structure to support its strategic initiatives, 
optimize the Company’s global supply chain to drive agility 
and efficiencies and simplify and streamline its 
organizational structure to reduce overhead costs
● Projected to result in cumulative pre-tax charges totaling 
between $200 and $300 million over the course of the 
three-year program*
*once all initiatives are approved and implemented
    9/29

    Loading...

    2025 Guidance - GAAP
● Net sales growth still expected to be up low single digits, now 
including a flat to low-single-digit negative impact from foreign 
exchange 
● Gross profit margin still expected to be roughly flat 
● Advertising still expected to be roughly flat as a percentage of 
net sales and on a dollar basis 
● GAAP EPS still expected to be up low single digits
Based on current spot rates and including the estimated impact of tariffs announced and finalized 
as of July 31, 2025:
    10/29

    Loading...

    2025 Guidance - Non-GAAP/Base Business
● Organic sales growth now expected to be at the low end of 2% 
to 4%, including the impact over the course of 2025 of the 
planned exit from private label pet sales 
● Gross profit margin still expected to be roughly flat 
● Advertising still expected to be roughly flat as a percentage of 
net sales and on a dollar basis 
● Base Business EPS still expected to be up low single digits
Based on current spot rates and including the estimated impact of tariffs announced and finalized 
as of July 31, 2025:
    11/29

    Loading...

    RAW & PACKAGING MATERIALS 
● Our expectations for underlying raw and packaging material cost inflation 
(excluding incremental tariffs) have risen given continued increases for fats 
and oils, particularly palm kernel oil.* 
● Our previous 2025 guidance, issued in April, included an incremental tariff 
impact of approximately $200 million to our cost of goods sold in 2025 versus 
the previous estimate provided in January. Our current expectation, given the 
tariffs announced and finalized as of July 31, 2025 by all countries, particularly 
those announced by the United States and China, is approximately $75 
million. These revised tariff costs are included in our guidance. If there are 
additional tariffs announced and implemented, we could incur additional costs.
*This forecast is based on our cost projections, which may differ from spot prices.
    12/29

    Loading...

    DRIVING OPERATING LEVERAGE & CASH FLOW
● Revenue growth management aiding pricing as 
inflationary pricing recedes
● Driving strong funding-the-growth savings
● Generating strong operating cash flow to fund 
dividends and share repurchases
    13/29

    Loading...

    DRIVING GROWTH THROUGH SCIENCE-LED, 
CORE AND PREMIUM INNOVATION
    14/29

    Loading...

    COLGATE’S “CHAIR TO SINK” 
WHITENING PORTFOLIO
TOOTHPASTE OVERNIGHT PEN EXPRESS PEN COMFORT FIT LED PROFESSIONAL 
TAKE-HOME
PROFESSIONAL 
IN-OFFICE
MOUTHWASH TOOTHBRUSH
EVERYDAY AT HOME WHITENING PROFESSIONAL
$4-10 $20 $25 $50 ~$200 ~$350
    15/29

    Loading...

    NEXT GENERATION OF THE 
OPTIC WHITE OVERNIGHT PEN
● Eliminates priming
● Automatic dosing
● Smooth application
Same powerful whitening performance 
powered by hydrogen peroxide – now 
designed with a sleek, easy-to-use 
applicator for precision and 
convenience
New 
wand 
applicator
    16/29

    Loading...

    ACCELERATING WHITENING ADOPTION 
WITH PURPLE RANGE
• Color corrects yellow tones* 
• Driving strong toothpaste share 
gains in key markets
• Now adding Colgate Optic White 
Purple Serum to the range - for a 
whitening boost when you need it
* effect is temporary
    17/29

    Loading...

    MIRACLE REPAIR SERUM 
TOOTHPASTE - CHINA
● Serum-infused toothpaste with 
breakthrough “Gum Revital 
Technology”
● Featuring dual ingredients amino acid 
+ antioxidant Vitamin C 
● Locks in the “collagen power” of 
gums and helps prevent gum 
collagen loss
    18/29

    Loading...

    COLGATE STRONG TEETH 
RELAUNCH IN INDIA
● #1 sub-brand in India
● Strengthened with a new formulation in 2025
● Calcium Boost + Arginine technology gives 2x 
stronger teeth*
● Supported with a high 
impact, multi-touch-point 
relaunch campaign
*vs. regular fluoride toothpaste
    19/29

    Loading...

    elmex SENSITIVITY+GUM
• Innovation strengthening our presence in the 
sensitivity segment
• elmex is now the 
#1 toothpaste brand 
recommended by 
dentists for sensitivity 
in Germany 
Source: Based on BRMO dentist study conducted in the relevant market
    20/29

    Loading...

    EltaMD UV SKIN RECOVERY
IS MORE THAN SPF
● Lightweight, 100% mineral SPF 50 
featuring our patented Skin Barrier 
Repair Technology, AAComplex
● Clinically proven to alleviate 
symptoms of skin sensitivity, like 
visible redness, a weakened skin 
barrier, dryness and roughness*
● 52% reduction in visible redness*
* 12 weeks study, 45 female subjects, all skin complexions and sensitive skin
Model featured. Enhanced for marketing purposes
    21/29

    Loading...

    PROTEX BAR SOAP 
RELAUNCH - Latin America
• 12-hour antibacterial protection* 
to strengthen the skin’s 
antibacterial defenses
• Enhanced package design and 
ad campaign highlighting 
Protex's leading efficacy
• Driving penetration gains across 
key markets
*After 2 weeks of daily use, increases antimicrobial peptide vs. same manufacturer's regular bar soap.
    22/29

    Loading...

    PALMOLIVE NATURALS 
RELAUNCH - Europe
• Nourishes skin 
• with Vitamin E
• Fragrances inspired by nature
• 95% natural origin formula
Source: Nielsen
    23/29

    Loading...

    SANEX DERMA THÉRAPIE LAUNCH 
• Formula with patented Amino Acid complex 
• Endorsed by dermatologists
• Premium positioning
    24/29

    Loading...

    SOUPLINE INFINITE FRESHNESS -
UNLOCKING GROWTH IN PREMIUM 
CONCENTRATION
• 4x More Longer Lasting 
Freshness*
• Ultra concentrated formula and 
our Just Washed Fragrance 
Technology delivers unbeatable 
freshness and softness
*vs Soupline Soft & Care
    25/29

    Loading...

    SUAVITEL COMPLETE ELEVATING
PRODUCT PERFORMANCE - 
MEXICO 
• Upgraded formula with 
improved color protection 
and a powerful fragrance 
system to support rewearing 
clothes maintaining its 
freshness between washes*
• New winning claim - 
“Ultra fresh all day” 
• Driving premiumization in the 
category
*Does not replace regular washing habits. Tested on garments such as sweaters and sweatshirts (outer layer). Follow usage instructions.
    26/29

    Loading...

    SCIENCE DIET 
CORE LIFESTAGE 
PORTFOLIO 
RELAUNCH
• Upgraded with ActivBiome+ 
Multi-Benefit, a blend of prebiotic fibers 
and antioxidants that support digestion, 
immune system and organ health
• Strong media support with new leading 
claim ‘Supports long, healthy lives’
    27/29

    Loading...

    PRESCRIPTION DIET NEW 
OPTIONS FOR COMPLEX CASES
• Multi-Organ: Therapeutic nutrition for complex multi-organ support in pets with 
conflicting nutritional needs
• Cognitive + Mobility: Therapeutic nutrition for pets to help support mind & mobility
    28/29

    Loading...

    NEW THERAPEUTIC PRODUCTS HELP 
ADDRESS KEY CONCERNS OF “SILENT 
SUFFERERS” 
• Many health concerns are 
difficult to see
• Pets suffer without support
• Media campaign educates on 
early recognition and 
proactively raising concerns 
with your vet
    29/29

    COLGATE-PALMOLIVE COMPANY 2Q 2025 EARNINGS PRESENTATION

    • 1. COLGATE-PALMOLIVE COMPANY 2Q 2025 EARNINGS PRESENTATION AUGUST 1, 2025
    • 2. August 2025 Notice for Investor Presentation Please review the following second quarter 2025 earnings presentation in conjunction with our second quarter 2025 earnings press release, our second quarter 2025 prepared management remarks and additional information regarding our non-GAAP financial measures, including GAAP to non-GAAP reconciliations, which are available in the Investor Center section of our website at www.colgatepalmolive.com/investors and in the second quarter 2025 earnings press release. Our presentation contains non-GAAP financial measures, which differ from our reported results prepared in accordance with U.S. generally accepted accounting principles (GAAP). These non-GAAP financial measures of operating results exclude items that, either by their nature or amount, management would not expect to occur as part of the Company’s normal business on a regular basis, such as restructuring charges, charges for certain litigation and tax matters, acquisition-related costs, gains and losses from certain divestitures and certain other unusual, non-recurring items. We may also refer to organic sales growth, which is Net sales growth excluding the impact of foreign exchange, acquisitions and divestments, or to free cash flow before dividends, which we define as Net cash provided by operations less Capital expenditures. A complete, quantitative reconciliation between our reported results and these non-GAAP financial measures is available in the Investor Center section of our website at www.colgatepalmolive.com/investors and in Tables 4, 6, 7, 8 and 9 of the second quarter 2025 earnings press release. Our presentation may contain forward-looking statements (as that term is defined in the U.S. Private Securities Litigation Reform Act of 1995 or by the Securities and Exchange Commission (the SEC) in its rules, regulations and releases) that set forth anticipated results based on management’s current plans and assumptions. These statements are made on the basis of our views and assumptions as of August 1, 2025, and we undertake no obligation to update these statements whether as a result of new information, future events or otherwise, except as required by law or by the rules and regulations of the SEC. Moreover, we do not, nor does any other person, assume responsibility for the accuracy and completeness of these statements. We caution investors that forward-looking statements are not guarantees of future performance and actual events or results may differ materially from those statements. For information about factors that could impact the Company’s business and cause actual results to differ materially from forward-looking statements, refer to the Company’s filings with the SEC (including, but not limited to, the information set forth under the captions “Risk Factors” and “Cautionary Statement on Forward-Looking Statements” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024 and subsequent filings with the SEC). Copies of these filings are available in the Investor Center section of our website at www.colgatepalmolive.com/investors or may be obtained upon request from the Company’s Investor Relations Department.
    • 3. COLGATE-PALMOLIVE We are a $20.1B global consumer products company with ~34,000 diverse and dedicated people serving over 200 countries and territories. As a caring, innovative growth company, we are united behind our purpose: reimagining a healthier future for all people, their pets and our planet.
    • 4. TIGHTLY FOCUSED ON FOUR ATTRACTIVE CORE CATEGORIES
    • 5. PERSONAL CARE HOME CARE ORAL CARE PET NUTRITION
    • 6. “I am pleased that Colgate-Palmolive people achieved another quarter of net sales, organic sales and earnings per share growth in the face of continued difficult market conditions worldwide, with organic sales growth improving sequentially versus the first quarter despite an even greater negative impact from lower private label pet sales.” - Noel Wallace, Chairman, President and Chief Executive Officer
    • 7. 2Q 2025 HIGHLIGHTS ● Delivered solid results, including net sales, organic sales and EPS growth, despite a challenging operating environment ● Net sales increased 1.0%; Organic sales* increased 1.8%, including a 0.6% negative impact from lower private label pet sales ● Organic sales increased sequentially versus 1Q 2025 ● Base Business EPS* increased 1% ● Global toothpaste market share was up 20 basis points on a volume basis year to date ● The acquisition of the Prime100 fresh pet food business closed on April 30, 2025 *Non-GAAP
    • 9. NEW PRODUCTIVITY PROGRAM ● Announced a new three-year productivity program to drive future growth and support the Company’s 2030 strategy ● Includes initiatives to better align the Company’s organizational structure to support its strategic initiatives, optimize the Company’s global supply chain to drive agility and efficiencies and simplify and streamline its organizational structure to reduce overhead costs ● Projected to result in cumulative pre-tax charges totaling between $200 and $300 million over the course of the three-year program* *once all initiatives are approved and implemented
    • 10. 2025 Guidance - GAAP ● Net sales growth still expected to be up low single digits, now including a flat to low-single-digit negative impact from foreign exchange ● Gross profit margin still expected to be roughly flat ● Advertising still expected to be roughly flat as a percentage of net sales and on a dollar basis ● GAAP EPS still expected to be up low single digits Based on current spot rates and including the estimated impact of tariffs announced and finalized as of July 31, 2025:
    • 11. 2025 Guidance - Non-GAAP/Base Business ● Organic sales growth now expected to be at the low end of 2% to 4%, including the impact over the course of 2025 of the planned exit from private label pet sales ● Gross profit margin still expected to be roughly flat ● Advertising still expected to be roughly flat as a percentage of net sales and on a dollar basis ● Base Business EPS still expected to be up low single digits Based on current spot rates and including the estimated impact of tariffs announced and finalized as of July 31, 2025:
    • 12. RAW & PACKAGING MATERIALS ● Our expectations for underlying raw and packaging material cost inflation (excluding incremental tariffs) have risen given continued increases for fats and oils, particularly palm kernel oil.* ● Our previous 2025 guidance, issued in April, included an incremental tariff impact of approximately $200 million to our cost of goods sold in 2025 versus the previous estimate provided in January. Our current expectation, given the tariffs announced and finalized as of July 31, 2025 by all countries, particularly those announced by the United States and China, is approximately $75 million. These revised tariff costs are included in our guidance. If there are additional tariffs announced and implemented, we could incur additional costs. *This forecast is based on our cost projections, which may differ from spot prices.
    • 13. DRIVING OPERATING LEVERAGE & CASH FLOW ● Revenue growth management aiding pricing as inflationary pricing recedes ● Driving strong funding-the-growth savings ● Generating strong operating cash flow to fund dividends and share repurchases
    • 14. DRIVING GROWTH THROUGH SCIENCE-LED, CORE AND PREMIUM INNOVATION
    • 15. COLGATE’S “CHAIR TO SINK” WHITENING PORTFOLIO TOOTHPASTE OVERNIGHT PEN EXPRESS PEN COMFORT FIT LED PROFESSIONAL TAKE-HOME PROFESSIONAL IN-OFFICE MOUTHWASH TOOTHBRUSH EVERYDAY AT HOME WHITENING PROFESSIONAL $4-10 $20 $25 $50 ~$200 ~$350
    • 16. NEXT GENERATION OF THE OPTIC WHITE OVERNIGHT PEN ● Eliminates priming ● Automatic dosing ● Smooth application Same powerful whitening performance powered by hydrogen peroxide – now designed with a sleek, easy-to-use applicator for precision and convenience New wand applicator
    • 17. ACCELERATING WHITENING ADOPTION WITH PURPLE RANGE • Color corrects yellow tones* • Driving strong toothpaste share gains in key markets • Now adding Colgate Optic White Purple Serum to the range - for a whitening boost when you need it * effect is temporary
    • 18. MIRACLE REPAIR SERUM TOOTHPASTE - CHINA ● Serum-infused toothpaste with breakthrough “Gum Revital Technology” ● Featuring dual ingredients amino acid + antioxidant Vitamin C ● Locks in the “collagen power” of gums and helps prevent gum collagen loss
    • 19. COLGATE STRONG TEETH RELAUNCH IN INDIA ● #1 sub-brand in India ● Strengthened with a new formulation in 2025 ● Calcium Boost + Arginine technology gives 2x stronger teeth* ● Supported with a high impact, multi-touch-point relaunch campaign *vs. regular fluoride toothpaste
    • 20. elmex SENSITIVITY+GUM • Innovation strengthening our presence in the sensitivity segment • elmex is now the #1 toothpaste brand recommended by dentists for sensitivity in Germany Source: Based on BRMO dentist study conducted in the relevant market
    • 21. EltaMD UV SKIN RECOVERY IS MORE THAN SPF ● Lightweight, 100% mineral SPF 50 featuring our patented Skin Barrier Repair Technology, AAComplex ● Clinically proven to alleviate symptoms of skin sensitivity, like visible redness, a weakened skin barrier, dryness and roughness* ● 52% reduction in visible redness* * 12 weeks study, 45 female subjects, all skin complexions and sensitive skin Model featured. Enhanced for marketing purposes
    • 22. PROTEX BAR SOAP RELAUNCH - Latin America • 12-hour antibacterial protection* to strengthen the skin’s antibacterial defenses • Enhanced package design and ad campaign highlighting Protex's leading efficacy • Driving penetration gains across key markets *After 2 weeks of daily use, increases antimicrobial peptide vs. same manufacturer's regular bar soap.
    • 23. PALMOLIVE NATURALS RELAUNCH - Europe • Nourishes skin • with Vitamin E • Fragrances inspired by nature • 95% natural origin formula Source: Nielsen
    • 24. SANEX DERMA THÉRAPIE LAUNCH • Formula with patented Amino Acid complex • Endorsed by dermatologists • Premium positioning
    • 25. SOUPLINE INFINITE FRESHNESS - UNLOCKING GROWTH IN PREMIUM CONCENTRATION • 4x More Longer Lasting Freshness* • Ultra concentrated formula and our Just Washed Fragrance Technology delivers unbeatable freshness and softness *vs Soupline Soft & Care
    • 26. SUAVITEL COMPLETE ELEVATING PRODUCT PERFORMANCE - MEXICO • Upgraded formula with improved color protection and a powerful fragrance system to support rewearing clothes maintaining its freshness between washes* • New winning claim - “Ultra fresh all day” • Driving premiumization in the category *Does not replace regular washing habits. Tested on garments such as sweaters and sweatshirts (outer layer). Follow usage instructions.
    • 27. SCIENCE DIET CORE LIFESTAGE PORTFOLIO RELAUNCH • Upgraded with ActivBiome+ Multi-Benefit, a blend of prebiotic fibers and antioxidants that support digestion, immune system and organ health • Strong media support with new leading claim ‘Supports long, healthy lives’
    • 28. PRESCRIPTION DIET NEW OPTIONS FOR COMPLEX CASES • Multi-Organ: Therapeutic nutrition for complex multi-organ support in pets with conflicting nutritional needs • Cognitive + Mobility: Therapeutic nutrition for pets to help support mind & mobility
    • 29. NEW THERAPEUTIC PRODUCTS HELP ADDRESS KEY CONCERNS OF “SILENT SUFFERERS” • Many health concerns are difficult to see • Pets suffer without support • Media campaign educates on early recognition and proactively raising concerns with your vet


    • Previous
    • Next
    • f Fullscreen
    • esc Exit Fullscreen